Liver Cancer Therapeutics Drugs and Companies Pipeline Review, H2 2016
Liver Cancer Pipeline Review, H2 2016', provides in depth analysis on therapeutics under development by companies & drug profiles study based on mechanism of action (MoA), route of administration (RoA) and molecule type